financetom
Business
financetom
/
Business
/
Neumora Therapeutics Insider Sold Shares Worth $370,962, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Neumora Therapeutics Insider Sold Shares Worth $370,962, According to a Recent SEC Filing
Oct 21, 2024 6:56 AM

09:29 AM EDT, 10/21/2024 (MT Newswires) -- Matthew K Fust, Director, around October 17, 2024, sold 21,788 shares in Neumora Therapeutics ( NMRA ) for $370,962. Following the Form 4 filing with the SEC, Fust has control over a total of 20,100 shares of the company, with 20,100 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1885522/000161071724000511/xslF345X05/form4.xml

Price: 16.01, Change: -0.48, Percent Change: -2.91

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved